Remote Ischemic Postconditioning in Septic Shock

NCT ID: NCT07273942

Last Updated: 2026-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

720 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-04-30

Study Completion Date

2028-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Septic shock is a leading cause of death worldwide despite intensive research efforts. Only a few interventions have been proven to be effective in improving patient-centered outcomes. Recent clinical trials have reported the safety and efficacy of remote ischemic postconditioning (RIPOST) in a variety of pathologies, including myocardial infarction, cardiac surgery, and stroke. While RIPOST was mainly tested in pathologies with low mortality rates, several follow-up studies of large randomized clinical trials in acute myocardial infarction and in patients undergoing coronary artery bypass surgery have reported significant decreases (\> 50%) in long-term mortality. Experimental studies and proof-of-concept clinical trials have also suggested the potential benefits of RIPOST on mortality in sepsis and septic shock. The present protocol aims to test whether this non-invasive, widely available, inexpensive, and innovative intervention can improve survival in septic shock.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult Patients With Septic Shock Admitted in Intensive Care Unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

In the control group, no intervention is performed.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Remote ischemic conditioning

A brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of alternating inflations and deflations of the brachial cuff. Four cycles of ischemic conditioning (5-min brachial cuff inflation at 200 mmHg followed by 5-min cuff deflation) are started as soon as possible after inclusion. The intervention is repeated 12 and 24 hours after inclusion.

Group Type EXPERIMENTAL

Remote ischemic conditioning

Intervention Type OTHER

A brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of alternating inflations and deflations of the brachial cuff. Four cycles of ischemic conditioning (5-min brachial cuff inflation at 200 mmHg followed by 5-min cuff deflation) are started as soon as possible after inclusion. The intervention is repeated 12 and 24 hours after inclusion.

Control group

No intervention wil be performed in the control group.

Group Type OTHER

No intervention

Intervention Type OTHER

No intervention will be performed in the conrol group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote ischemic conditioning

A brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of alternating inflations and deflations of the brachial cuff. Four cycles of ischemic conditioning (5-min brachial cuff inflation at 200 mmHg followed by 5-min cuff deflation) are started as soon as possible after inclusion. The intervention is repeated 12 and 24 hours after inclusion.

Intervention Type OTHER

No intervention

No intervention will be performed in the conrol group

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Hospitalized in intensive care unit for less than 24 hours
* Septic shock (Sepsis-3 definition) evolving for less than 18 hours
* Preliminary written informed consent obtained from the patient or his/her close relative, or use of the emergency procedure in accordance with local regulations

Exclusion Criteria

* Contraindication of the use of a brachial pressure cuff on both arms
* Cardiac arrest
* Pregnancy or breast feeding
* Participation in another interventional study
* Lack of French national health insurance coverage
* Patient with any legal protection measure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Réanimation Médicale, Hôpital Jean-Minjoz, CHU de Besançon

Besançon, , France

Site Status

Service Réanimation Polyvalente, Centre Hospitalier de Fleyriat

Bourg-en-Bresse, , France

Site Status

Service de Médecine Intensive- Réanimation, Hôpital Gabriel Montpied, CHU de Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris

Créteil, , France

Site Status

Service de Médecine intensive-Réanimation,Hôpital F Mitterrand, CHU de Dijon

Dijon, , France

Site Status

Service de Médecine intensive-Réanimation,Hôpital Albert Michallon, CHU de Grenoble

La Tronche, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris

Le Kremlin-Bicêtre, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Salengro, CHU de Lille

Lille, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon

Lyon, , France

Site Status

Service Réanimation Polyvalente, Hôpital Saint-Joseph Saint-Luc

Lyon, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Nord, Assistance Publique des Hôpitaux de Marseille

Marseille, , France

Site Status

Service de Réanimation des Urgences, Hôpital de la Timone, CHU de Marseille

Marseille, , France

Site Status

Service de Médecine intensive-Réanimation, Hôpital Lapeyronie, CHU de Montpellier

Montpellier, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Central, CHRU de Nancy

Nancy, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôtel Dieu, CHU de Nantes

Nantes, , France

Site Status

Service de Médecine Intensive - Réanimation, Hôpital Cochin, Assistance Publique des Hôpitaux de Paris

Paris, , France

Site Status

Service d'Anesthésie - Réanimation - Médecine Intensive, Hôpital Lyon Sud, Hospices Civils de Lyon

Pierre-Bénite, , France

Site Status

Service de Médecine Intensive et Réanimation Polyvalente, Hôpital Robert Debré, CHU Reims

Reims, , France

Site Status

Service des maladies infectieuses et réanimation médicale, Hôpital Pontchaillou, CHU de Rennes

Rennes, , France

Site Status

Service Réanimation Polyvalente, Centre Hospitalier de Roanne

Roanne, , France

Site Status

Service de Médecine intensive-Réanimation, Hôpital Nord, CHU de St Etienne

Saint-Priest-en-Jarez, , France

Site Status

Service de Médecine Intensive-Réanimation, Nouvel Hôpital Civil, CHU de Strasbourg

Strasbourg, , France

Site Status

Service de Médecine Intensive-Réanimation, Hôpital Bretonneau, CHRU de Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Martin COUR, MD

Role: CONTACT

4 72 11 28 52 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gaël PITON, MD

Role: primary

François DHELFT, MD

Role: primary

Maxime DUMESNIL, MD

Role: primary

Armand MEKONTSO-DESSAP, MD

Role: primary

Jean-Pierre QUENOT, MD

Role: primary

Carole SCHWEBEL, MD

Role: primary

Tai PHAM, MD

Role: primary

Raphaël FAVORY, MD

Role: primary

Martin COUR, MD

Role: primary

Emmanuel VIVIER, MD

Role: primary

Sami HRAIECH, MD

Role: primary

Marc GAINNIER, MD

Role: primary

Kada KLOUCHE, MD

Role: primary

Sébastien GIBOT, MD

Role: primary

Jean REIGNIER, MD

Role: primary

Jean-Paul MIRA, MD

Role: primary

Auguste DARGENT, MD

Role: primary

David BUSSY, MD

Role: primary

Félicie BELICARD, MD

Role: primary

Pascal BEURET, MD

Role: primary

Sophie PERINEL, MD

Role: primary

Hamid MERDJI, MD

Role: primary

Juliette POCQUET, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL24_0937

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Shock and Acute Conditions OutcOmes Platform
NCT06376318 ACTIVE_NOT_RECRUITING
Septic Shock em Steroids
NCT01047670 UNKNOWN PHASE2/PHASE3